A Factor VIII Concentrate, Highly Purified and Heated in Solution
Author(s) -
N. Heimburger,
Horst Schwinn,
P. Gratz,
G. Kumpe,
B. Herchenhan
Publication year - 1981
Publication title -
pathophysiology of haemostasis and thrombosis
Language(s) - English
Resource type - Journals
eISSN - 1424-8840
pISSN - 1424-8832
DOI - 10.1159/000214550
Subject(s) - chemistry , factor (programming language) , factor ix , chromatography , biochemistry , computer science , programming language
A Factor VIII Concentrate, Highly Purified and Heated in Solution N. Heimburger H. Schwinn P. Gratz G. Kumpe B. Herchenhan N.Heimburger, Albert-Demnitz-Weg 3, D-3550 Marburg-Marbach (FRG) A method to produce a highly purified factor VIII concentrate, heated in solution, is described: Pooled cryoprecipitate from citrate plasma is adsorbed on aluminium hydroxide. The fibrinogen is removed by heat denaturation in the presence of glycine, and the factor VIII remaining in the supernatant is precipitated with sodium chloride. This precipitate is dissolved in a sucroseglycine solution which is heated for 10 h at a temperature of 60 °C. The factor VIII is then separated by re-precipitation with sodium chloride. Subsequently, it is dissolved, dia-lyzed, and filtered under sterile conditions through membrane filters. The factor VIII concentrate contains 3.5 units of factor VIII: C/mg protein. The ratio factor VIII R:Ag _í factor VIII: C ~ ¿’ The product is free from coagulable protein and protein globulins. The yield of factor VIII is about 8% of the initial plasma. The reduction in infectiousness obtained by heating was assessed in a study on chimpanzees; in these experiments, hepatitis B virus was added to the cryoprecipitate pool.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom